Literature DB >> 30807646

CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination.

Yanjie Kong1,2, Zehua Wang1, Maobo Huang1, Zhongmei Zhou1, Yi Li3, Huilai Miao4, Xing Wan5, Jian Huang2, Xiaoyun Mao6, Ceshi Chen1,2,7.   

Abstract

The Cullin 7 (CUL7) gene encodes a member of the cullin family of E3 ubiquitin ligases. Accumulated evidence suggests that CUL7 is oncogenic. However, the mechanism by which CUL7 improves cancer cell survival has not been fully elucidated. Here, we reported that CUL7 confers anti-apoptotic functions by interacting with Caspase-8. CUL7 prevents Caspase-8 activation by promoting Caspase-8 modification with non-degradative polyubiquitin chains at K215. CUL7 knockdown sensitized cancer cells to TRAIL-induced apoptosis in vitro and in nude mice. These results suggest that CUL7 limits extrinsic apoptotic signaling by promoting Caspase-8 ubiquitination.
© 2019 UICC.

Entities:  

Keywords:  CUL7; Caspase-8; apoptosis; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 30807646     DOI: 10.1002/ijc.32239

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  The role of E3 ubiquitin ligase HECTD3 in cancer and beyond.

Authors:  Qiuyun Jiang; Fubing Li; Zhuo Cheng; Yanjie Kong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

Review 2.  Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.

Authors:  Zhen-Qiang Pan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.

Authors:  Jianye Xu; Zongpu Zhang; Mingyu Qian; Shaobo Wang; Wei Qiu; Zihang Chen; Zhongzheng Sun; Ye Xiong; Chaochao Wang; Xiaopeng Sun; Rongrong Zhao; Hao Xue; Gang Li
Journal:  J Exp Clin Cancer Res       Date:  2020-04-06

4.  Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy.

Authors:  Maximilian Knoll; Maria Waltenberger; Jennifer Furkel; Ute Wirkner; Aoife Ward Gahlawat; Ivana Dokic; Christian Schwager; Sebastian Adeberg; Stefan Rieken; Tobias Kessler; Felix Sahm; Laila König; Christel Herold-Mende; Stephanie E Combs; Jürgen Debus; Amir Abdollahi
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

5.  Evaluation of Silver Nanoparticles Caffeic Acid Complex Compound as New Potential Therapeutic Agent against Cancer Incidence in Mice.

Authors:  Tahany Saad Abdelwahab; Rania Ellisy Abdelhamed; Eman Noaman Ali; Nahla Ahmed Mansour; Mohga Shafik Abdalla
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

Review 6.  Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer.

Authors:  Trace M Jones; Jennifer S Carew; Julie E Bauman; Steffan T Nawrocki
Journal:  Cancers (Basel)       Date:  2021-06-29       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.